AMT-260 — Conference presentation
H1 2027
The Company expects to present updated results from the Phase I/IIa study in the first half of 2027.Source filing
QURE biotech catalysts & pipeline
UNIQURE NV · Data as of 2026-10-25
catalyst calendar
/
catalyst calendar
UNIQURE NV · Data as of 2026-10-25
H1 2027
The Company expects to present updated results from the Phase I/IIa study in the first half of 2027.Source filing